Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
HCA Healthcare
HCA
|
$458M |
| 2 |
Booking.com
BKNG
|
$328M |
| 3 |
Alibaba
BABA
|
$255M |
| 4 |
RTX Corp
RTX
|
$248M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
$232M |
Top Sells
| 1 |
Apple
AAPL
|
$444M |
| 2 |
Boston Properties
BXP
|
$436M |
| 3 |
JPMorgan Chase
JPM
|
$427M |
| 4 |
Citigroup
C
|
$353M |
| 5 |
Microsoft
MSFT
|
$329M |
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Healthcare | 13.45% |
| 3 | Financials | 12.92% |
| 4 | Consumer Discretionary | 12.35% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Element Solutions
ESI
$6.33B
| $66.8M | 0.02% |
6,155,700
+664,581
| +12% | +$7.21M |
|
777
BioMarin Pharmaceuticals
BMRN
$11.1B
| $66.7M | 0.02% |
540,912
+12,772
| +2% | +$1.58M |
|
778
KBR
KBR
$6.4B
| $66.6M | 0.02% |
2,951,211
-2,593,948
| -47% | -$58.5M |
|
779
Agios Pharmaceuticals
AGIO
$2.09B
| $66.5M | 0.02% |
1,243,239
+24,188
| +2% | +$1.29M |
|
780
Cboe Global Markets
CBOE
$24.3B
| $66.4M | 0.02% |
711,675
-438,753
| -38% | -$40.9M |
|
781
Fortune Brands Innovations
FBIN
$7.3B
| $66M | 0.02% |
1,207,546
-91,444
| -7% | -$5M |
|
782
NOV
NOV
$4.95B
| $65.8M | 0.02% |
5,367,673
+1,384,799
| +35% | +$17M |
|
783
Valmont Industries
VMI
$7.46B
| $65.6M | 0.02% |
576,985
+379,831
| +193% | +$43.2M |
|
784
Leggett & Platt
LEG
$1.35B
| $65.4M | 0.02% |
1,861,245
+633,019
| +52% | +$22.3M |
|
785
Invesco Fundamental High Yield Corporate Bond ETF
PHB
$354M
| $65.4M | 0.02% |
3,611,164
+1,054,416
| +41% | +$19.1M |
|
786
Natera
NTRA
$23.1B
| $65M | 0.02% |
1,304,477
+60,390
| +5% | +$3.01M |
|
787
BCE
BCE
$23.1B
| $64.9M | 0.02% |
1,554,525
-428,697
| -22% | -$17.9M |
|
788
Loews
L
$20B
| $64.8M | 0.02% |
1,890,128
-1,507,426
| -44% | -$51.7M |
|
789
Southwest Airlines
LUV
$16.5B
| $64.7M | 0.02% |
1,891,823
+153,228
| +9% | +$5.24M |
|
790
Trimble
TRMB
$19.2B
| $64.2M | 0.02% |
1,486,824
-414,875
| -22% | -$17.9M |
|
791
Descartes Systems
DSGX
$9.26B
| $64.2M | 0.02% |
1,212,883
-525,284
| -30% | -$27.8M |
|
792
Hanover Insurance
THG
$6.35B
| $63.7M | 0.02% |
628,429
-96,081
| -13% | -$9.74M |
|
793
Emergent Biosolutions
EBS
$404M
| $63.4M | 0.02% |
802,037
-110,187
| -12% | -$8.71M |
|
794
Fortive
FTV
$16.2B
| $63.4M | 0.02% |
1,118,992
-130,531
| -10% | -$7.39M |
|
|
IMMU
795
DELISTED
Immunomedics Inc
IMMU
| $63.3M | 0.02% |
1,786,596
+1,241,631
| +228% | +$44M |
|
796
Everest Group
EG
$14.3B
| $63.3M | 0.02% |
307,007
-345,808
| -53% | -$71.3M |
|
|
CUB
797
DELISTED
Cubic Corporation
CUB
| $63.1M | 0.02% |
1,314,528
+175,291
| +15% | +$8.42M |
|
|
ETFC
798
DELISTED
E*Trade Financial Corporation
ETFC
| $63M | 0.02% |
1,267,207
-746,734
| -37% | -$37.1M |
|
799
Lincoln National
LNC
$7.98B
| $63M | 0.02% |
1,712,626
-137,412
| -7% | -$5.06M |
|
|
GAP
800
The Gap, Inc.
GAP
$8.83B
| $62.9M | 0.02% |
4,985,233
-2,926,214
| -37% | -$36.9M |
|